Archive for the ‘Uncategorized’ Category

Qu Biologics Completes Enrollment in First Stage of Phase 2 Clinical Trial in Moderate to Severe Crohn’s Disease

Thursday, December 19th, 2019

VANCOUVER, British Columbia – Dec. 18, 2019 (GLOBE NEWSWIRE) — Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform designed to restore innate immune function, is pleased to announce the completion of enrollment for the first stage of the RESTORE clinical trial, “A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled […]

Protected: IBD Advisory Panel meeting March 6 2018

Wednesday, March 21st, 2018

There is no excerpt because this is a protected post.

Qu Biologics Named Life Sciences BC Growth Stage Company of the Year

Wednesday, March 4th, 2015

Vancouver, British Columbia – March 4, 2015 – Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body’s normal immune function in the targeted diseased organ, is pleased to announce it has been selected as the 2015 BC Growth Stage Life Sciences Company of the Year. Life Sciences […]

Past events:


Past events: